159 related articles for article (PubMed ID: 4677595)
1. Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.
Burgess MA; Bodey GP
Antimicrob Agents Chemother; 1972 Dec; 2(6):423-6. PubMed ID: 4677595
[TBL] [Abstract][Full Text] [Related]
2. Laboratory assessment of the antimycotic drug clotrimazole.
Holt RJ; Newman RL
J Clin Pathol; 1972 Dec; 25(12):1089-97. PubMed ID: 4655860
[TBL] [Abstract][Full Text] [Related]
3. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
Shadomy S; Dixon DM; May R
Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
[TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).
Marks MI; Steer P; Eickhoff TC
Appl Microbiol; 1971 Jul; 22(1):93-5. PubMed ID: 5165106
[TBL] [Abstract][Full Text] [Related]
5. Superficial mycoses and in vitro sensitivity of dermatophytes and Candida species to tolciclate and clotrimazole.
Jacob Z; Wahab S; Ghosh M; Srivastava OP
Indian J Med Res; 1981 Sep; 74():365-71. PubMed ID: 7319573
[No Abstract] [Full Text] [Related]
6. In vitro antifungal activity of clotrimazole (Bay b 5097).
Shadomy S
Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action of clotrimazole. I. Study of the principal action on Candida albicans].
Iwata K; Yamaguchi H
Nihon Saikingaku Zasshi; 1973 Nov; 28(6):513-21. PubMed ID: 4597146
[No Abstract] [Full Text] [Related]
8. [Mechanisl of action of clotrimazole. 2. Effects on the cell membrane of Candida albicans].
Yamaguchi H; Iwata K
Nihon Saikingaku Zasshi; 1974 Mar; 29(2):379-85. PubMed ID: 4603678
[No Abstract] [Full Text] [Related]
9. The therapy of candida vaginitis and candida vulvovaginitis with a new antimycotic substance, clotrimazole.
Tamura S; Kuramoto H; Yamada T; Majima H; Miyamoto H
Curr Med Res Opin; 1973; 1(9):540-6. PubMed ID: 4591822
[No Abstract] [Full Text] [Related]
10. In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
Torres-Rodríguez JM; Mendez R; López-Jodra O; Morera Y; Espasa M; Jimenez T; Lagunas C
Antimicrob Agents Chemother; 1999 May; 43(5):1258-9. PubMed ID: 10223946
[TBL] [Abstract][Full Text] [Related]
11. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
Berg D; Regel E; Harenberg HE; Plempel M
Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
[TBL] [Abstract][Full Text] [Related]
12. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Odds FC; Webster CE; Abbott AB
J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
[TBL] [Abstract][Full Text] [Related]
13. Topical treatment with clotrimazole in dermatomycosis.
Gip L
Curr Ther Res Clin Exp; 1974 Jan; 16(1):27-31. PubMed ID: 4203845
[No Abstract] [Full Text] [Related]
14. Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).
Waitz JA; Moss EL; Weinstein MJ
Appl Microbiol; 1971 Nov; 22(5):891-8. PubMed ID: 4943591
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
16. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro].
Pospisil J
Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472
[TBL] [Abstract][Full Text] [Related]
17. In vitro sensitivity of Candida (Torulopsis) glabrata to clotrimazole.
Fagnant JE; Clark RB; Monif GR
Am J Reprod Immunol; 1989 Jan; 19(1):38-40. PubMed ID: 2765132
[TBL] [Abstract][Full Text] [Related]
18. Phycomycosis of the kidney associated with a transient immune defect and treated with clotrimazole.
Low AI; Tulloch AG; England EJ
J Urol; 1974 Jun; 111(6):732-4. PubMed ID: 4830872
[No Abstract] [Full Text] [Related]
19. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Candida pyuria with the oral antigungal drug Bay b 5097 (author's transl)].
Exss R; Azubuike JC
Padiatr Padol; 1973; 8(4):433-5. PubMed ID: 4583282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
